KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to -$51.5 million.

  • Zimmer Biomet Holdings' Change in Accured Expenses fell 12198.28% to -$51.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$128.4 million, marking a year-over-year decrease of 21703.7%. This contributed to the annual value of -$322.0 million for FY2024, which is 48227.85% down from last year.
  • Latest data reveals that Zimmer Biomet Holdings reported Change in Accured Expenses of -$51.5 million as of Q3 2025, which was down 12198.28% from $76.8 million recorded in Q2 2025.
  • Zimmer Biomet Holdings' Change in Accured Expenses' 5-year high stood at $164.2 million during Q4 2023, with a 5-year trough of -$138.3 million in Q1 2021.
  • In the last 5 years, Zimmer Biomet Holdings' Change in Accured Expenses had a median value of -$34.0 million in 2022 and averaged -$10.5 million.
  • In the last 5 years, Zimmer Biomet Holdings' Change in Accured Expenses tumbled by 47735.85% in 2023 and then soared by 22367.15% in 2025.
  • Zimmer Biomet Holdings' Change in Accured Expenses (Quarter) stood at $64.0 million in 2021, then skyrocketed by 63.44% to $104.6 million in 2022, then surged by 56.98% to $164.2 million in 2023, then crashed by 171.44% to -$117.3 million in 2024, then skyrocketed by 56.1% to -$51.5 million in 2025.
  • Its Change in Accured Expenses stands at -$51.5 million for Q3 2025, versus $76.8 million for Q2 2025 and -$36.4 million for Q1 2025.